首页> 外文期刊>International Journal of Pharmaceutics >Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
【24h】

Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.

机译:顺铂聚乳酸-乙醇酸微球的靶向肺研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Lung-targeting cisplatin-loaded poly(lactic-co-glycolic) acid microspheres (CDDP-PLGA-MS) were prepared by a solvent evaporation method. The uniform design was used to optimize the technology of preparation, the appearance and size distribution were examined by scanning electron microscope, and the aspects such as in vitro release characteristics, stability, drug loading, loading efficiency, pharmacokinetics and tissue distribution in rabbit were studied. The experimental results showed that the microspheres were globular in appearance and dispersed well. The average particle size was 12.8 microm with 98% of the microspheres being in the range of 5-30 microm. The drug loading and loading efficiency were 17.68 and 53.2%, respectively. The in vitro release behavior could be expressed by the following equation: 1-Q=0.424e(-0.360t)+0.474e(-0.001t). After i.v. administration (15 min), the drug concentration of microspheres group in lung in rabbits was 212 microg/g, while that of controlled group was 1.37 microg/g. CDDP-PLGA-MS showed a combination of lung-targeting and sustained drug release in experiments on rabbits.
机译:通过溶剂蒸发法制备了靶向肺的顺铂负载聚乳酸-乙醇酸共聚物微球(CDDP-PLGA-MS)。采用统一的设计优化制备工艺,通过扫描电镜观察外观和大小分布,研究了兔体内的体外释放特性,稳定性,载药量,载药效率,药代动力学和组织分布等方面。实验结果表明,微球外观呈球形且分散良好。平均粒度为12.8微米,其中98%的微球在5-30微米的范围内。载药量和载药效率分别为17.68和53.2%。体外释放行为可用以下方程式表示:1-Q = 0.424e(-0.360t)+ 0.474e(-0.001t)。在i.v.之后给药(15分钟),家兔肺微球组药物浓度为212微克/克,对照组为1.37微克/克。 CDDP-PLGA-MS在兔子实验中显示出肺靶向和持续药物释放的组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号